Zobrazeno 1 - 10
of 29
pro vyhledávání: '"D. G. Priest"'
Autor:
Z. Chen, D. G. Priest, M. Bunni, J. L. DiCapua, Peter W. Melera, Wei-Yong Zhu, J. M. Dressler
Publikováno v:
Journal of Experimental Therapeutics and Oncology. 2:264-277
DC-3F/FA3 cells (FA3) were derived from antifolate-sensitive CHL cells by selection for growth in folate-free media containing 15 pM [6S]-5CHOFH4. These cells undergo a 30-fold decrease in intracellular folates, overexpress folate receptor alpha (FR
Autor:
G. Jansen, Y. G. Assaraf, D. G. Priest, M. Bunni, M. Kool, I. Kathmann, J. H. Hooijberg, R. J. Scheper, B. A. C. Dijkmans, G. J. Kaspers, G. J. Peters
Publikováno v:
Chemistry and Biology of Pteridines and Folates ISBN: 9781461353171
Cellular folate homeostasis is essential to allow continuous use of reduced folate cofactors for a variety of biosynthetic processes including purine and pyrimidine biosynthesis, mitochondrial protein synthesis and amino acid biosynthesis. Beyond thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7e1c311b149fc56d5160ea6fe23b8fd
https://doi.org/10.1007/978-1-4615-0945-5_108
https://doi.org/10.1007/978-1-4615-0945-5_108
Autor:
C L, van der Wilt, H H, Backus, K, Smid, L, Comijn, G, Veerman, D, Wouters, D A, Voorn, D G, Priest, M A, Bunni, F, Mitchell, A L, Jackman, G, Jansen, G J, Peters
Publikováno v:
Cancer research. 61(9)
Plasma levels of folates and thymidine in mice are about 10-fold higher than in humans and may influence the therapeutic efficacy of thymidylate synthase (TS) inhibitors, such as 5-fluorouracil (5FU) and the antifolates pemetrexed (MTA) and raltitrex
Autor:
H L, McLeod, J, Cassidy, R H, Powrie, D G, Priest, M A, Zorbas, T W, Synold, S, Shibata, D, Spicer, D, Bissett, Y K, Pithavala, M A, Collier, L J, Paradiso, J D, Roberts
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(7)
Glycinamide ribonucleotide formyltransferase (GARFT) is a component of the de novo purine synthesis pathway. AG2034 is a specific inhibitor of GARFT that was designed based on the GARFT crystal structure. In conjunction with Phase I studies at four c
Publikováno v:
Seminars in oncology. 26(2 Suppl 6)
The pharmacokinetics of folic acid, and resultant metabolites thereof, have been determined after administration orally and intravenously at 25 mg/m2 and 125 mg/m2. Saturation behavior was observed for uptake of folic acid into plasma and with regard
Autor:
G, Jansen, H, Barr, I, Kathmann, M A, Bunni, D G, Priest, P, Noordhuis, G J, Peters, Y G, Assaraf
Publikováno v:
Molecular pharmacology. 55(4)
Chinese hamster ovary PyrR100 cells display more than 1000-fold resistance to pyrimethamine (Pyr), a lipophilic antifolate inhibitor of dihydrofolate reductase. PyrR100 cells had wild-type DHFR activity, lost folate exporter activity, and had a 4-fol
Autor:
G, Pizzorno, B A, Moroson, A R, Cashmore, O, Russello, J R, Mayer, J, Galivan, M A, Bunni, D G, Priest, G P, Beardsley
Publikováno v:
Cancer research. 55(3)
5,10-dideaza-5,6,7,8-terrahydrofolic acid (DDATHF) is a potent antiproliferative agent in cell culture systems and in vivo in a number of murine and human xenograft tumors. In contrast to classical antifolates, which are dihydrofolate reductase inhib
Publikováno v:
Biochemical pharmacology. 48(2)
To investigate the role of dietary folic acid in dideazatetrahydrofolate (DDATHF) sensitivity, reduced folates were estimated in plasma and tissue of mice following dietary depletion and repletion. Previous studies showed that DDATHF, a new folate an
Publikováno v:
Advances in experimental medicine and biology. 338
Publikováno v:
Advances in experimental medicine and biology. 338